X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (75) 75
Patent (57) 57
Publication (13) 13
Book Review (9) 9
Book / eBook (4) 4
Book Chapter (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (50) 50
human necessities (50) 50
hygiene (50) 50
medical or veterinary science (50) 50
metallurgy (50) 50
organic chemistry (50) 50
preparations for medical, dental, or toilet purposes (49) 49
peptides (45) 45
specific therapeutic activity of chemical compounds ormedicinal preparations (28) 28
humans (24) 24
index medicus (21) 21
male (18) 18
female (17) 17
middle aged (16) 16
cardiac & cardiovascular systems (15) 15
adult (14) 14
double-blind method (14) 14
cholesterol (13) 13
alirocumab (12) 12
cardiovascular (12) 12
history (12) 12
treatment outcome (12) 12
hypercholesterolemia (11) 11
pcsk9 (11) 11
abridged index medicus (10) 10
cholesterol, ldl - blood (10) 10
hypercholesterolemia - drug therapy (10) 10
therapy (10) 10
atorvastatin (9) 9
efficacy (9) 9
lipids (9) 9
monoclonal antibodies (9) 9
monoclonal-antibody (9) 9
aged (8) 8
antibodies, monoclonal - administration & dosage (8) 8
drug therapy, combination (8) 8
safety (8) 8
antibodies, monoclonal - therapeutic use (7) 7
cardiovascular disease (7) 7
obesity - drug therapy (7) 7
physics (7) 7
statins (7) 7
acute coronary syndrome (6) 6
acute coronary syndromes (6) 6
analysis (6) 6
atorvastatin calcium (6) 6
density-lipoprotein cholesterol (6) 6
disease (6) 6
internal medicine (6) 6
low density lipoprotein (6) 6
low density lipoproteins (6) 6
mortality (6) 6
rheology (6) 6
antibodies, monoclonal - adverse effects (5) 5
anticholesteremic agents - administration & dosage (5) 5
anticholesteremic agents - therapeutic use (5) 5
cardiovascular diseases - prevention & control (5) 5
care and treatment (5) 5
diabetes (5) 5
dose-response relationship, drug (5) 5
drug therapy (5) 5
endocrinology & metabolism (5) 5
heart attacks (5) 5
heterocyclic compounds (5) 5
hypercholesterolemia - blood (5) 5
literature, romance (5) 5
obesity (5) 5
proprotein convertase 9 (5) 5
proprotein convertases - antagonists & inhibitors (5) 5
risk (5) 5
statin therapy (5) 5
weight loss - drug effects (5) 5
[ spi.gproc ] engineering sciences [physics]/chemical and process engineering (4) 4
adolescent (4) 4
angina (4) 4
angina pectoris (4) 4
calculating (4) 4
cardiology and cardiovascular medicine (4) 4
cerebral infarction (4) 4
chemical and process engineering (4) 4
computing (4) 4
condensed matter (4) 4
coronary heart disease (4) 4
counting (4) 4
death (4) 4
electric communication technique (4) 4
electric digital data processing (4) 4
electricity (4) 4
engineering sciences (4) 4
ezetimibe (4) 4
follow-up studies (4) 4
health risk assessment (4) 4
heart diseases (4) 4
heptanoic acids - administration & dosage (4) 4
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (4) 4
ischemia (4) 4
lipoproteins (4) 4
materials science, multidisciplinary (4) 4
medicine, general & internal (4) 4
metaanalysis (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (110) 110
French (57) 57
Spanish (8) 8
Chinese (6) 6
German (6) 6
Korean (4) 4
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Journal Article
by Jukema, JW and Szarek, M and Zijlstra, LE and de Silva, HA and Bhatt, DL and Bittner, VA and Diaz, R and Edelberg, JM and Goodman, SG and Hanotin, C and Harrington, RA and Karpov, Y and Moryusef, A and Pordy, R and Prieto, JC and Roe, MT and White, HD and Zeiher, AM and Schwartz, GG and Steg, PG and Tricoci, P and Mahaffey, KW and Lecorps, G and Sasiela, WJ and Tamby, JF and Aylward, PE and Drexel, H and Sinnaeve, P and Dilic, M and Gotcheva, NN and Yong, H and Lopez-Jaramillo, P and Pecin, I and Reiner, Z and Ostadal, P and Poulsen, SH and Viigimaa, M and Nieminen, MS and Danchin, N and Chumburidze, V and Marx, N and Liberopoulos, E and Valdovinos, PCM and Tse, HF and Kiss, RG and Xavier, D and Zahger, D and Valgimigli, M and Kimura, T and Kim, HS and Kim, SH and Kedev, S and Erglis, A and Laucevicius, A and Yusoff, K and Lopez, R and Lopez, GAR and Alings, M and Halvorsen, S and Flores, RMC and Sy, RG and Budaj, A and Morais, J and Dorobantu, M and Ristic, AD and Chua, T and Murin, J and Fras, Z and Dalby, AJ and Tunon, J and De Silva, HA and Hagstrom, E and Muller, C and Chiang, CE and Sritara, P and Guneri, S and Parkhomenko, A and Ray, KK and Moriarty, PM and Chaitman, B and Kelsey, SF and Olsson, AG and Rouleau, JL and Simoons, ML and Alexander, K and Meloni, C and Rosenson, R and Sijbrands, EJG and Alexander, JH and Armaganijan, L and Bagai, A and Bahit, MC and Brennan, JM and Clifton, S and DeVore, AD and Deloatch, S and Dickey, S and Dombrowski, K and Ducrocq, G and Eapen, Z and ... and ODYSSEY OUTCOMES Comm Investigator and ODYSSEY OUTCOMES Committees and Investigators
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 09/2019, Volume 74, Issue 9, pp. 1167 - 1176
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2013, Volume 34, Issue suppl 1, pp. 142 - 142
Journal Article
by Ray, Kausik K and Ray, Michael and Colhoun, Helen M and Szarek, Michael and Baccara-Dinet, Marie and Bhatt, Deepak L and Bittner, Vera A and Budaj, Andrzej J and Budaj, Andrzej and Diaz, Rafael and Diaz, Ariel and Goodman, Shaun G and Hanotin, Corinne and Harrington, Robert A and Jukema, J Wouter and Jukema, J. Wouter and Jukema, Johan and Loizeau, Virginie and Lopes, Renato D and Lopes, Renato and Moryusef, Angèle and Murin, Jan and Pordy, Robert and Ristic, Arsen D and Roe, Matthew T and Tuñón, José and White, Harvey D and White, Matthew and White, Lindsey and Zeiher, Andreas M and Schwartz, Steven and Schwartz, Michael and Schwartz, Gregory G and Steg, Philippe Gabriel and Steg, Ph. Gabriel and Tricoci, Pierluigi and Mahaffey, Kenneth W and Edelberg, Jay M and Lecorps, Guillaume and Sasiela, William J and Tamby, Jean-François and Aylward, Philip E and Drexel, Heinz and Sinnaeve, Peter and Dilic, Mirza and Gotcheva, Nina N and Prieto, Juan-Carlos and Prieto, Juan C and Yong, Huo and López-Jaramillo, Patricio and Pećin, Ivan and Reiner, Zeljko and Ostadal, Petr and Viigimaa, Margus and Nieminen, Markku S and Chumburidze, Vakhtang and Marx, Roger and Marx, Nikolaus and Danchin, Nicolas and Liberopoulos, Evangelos and Montenegro Valdovinos, Pablo Carlos and Tse, Hung-Fat and Kiss, Robert Gabor and Xavier, Denis and Zahger, Doron and Valgimigli, Marco and Kimura, Kazuo and Kimura, Takeshi and Kim, Sang-Hyun and Kim, Youngkwon and Kim, Chongjin and Kim, Hyo Soo and Kim, Hack-Lyoung and Kim, Moo Hyun and Kim, Hyo-Soo and Kim, Hae Young and Erglis, Andrejs and Laucevicius, Aleksandras and Kedev, Sasko and Yusoff, Khalid and Ramos López, Gabriel Arturo and Alings, Marco and Halvorsen, Sigrun and Correa Flores, Roger M and Morais, Joao and Dorobantu, Maria and Karpov, Yuri and Karpov, Yuriy and Chua, Terrance and Fras, Zlatko and Dalby, Anthony J and de Silva, H. Asita and Hagström, Emil and Landmesser, Ulf and Chiang, Chern-En and Sritara, Piyamitr and Guneri, Sema and Parkhomenko, Alexander and Moriarty, Patrick M and Moriarty, Katie and ... and ODYSSEY OUTCOMES Comm Investigato and ODYSSEY OUTCOMES Committees and Investigators
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2019, Volume 7, Issue 8, pp. 618 - 628
After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with... 
MYOCARDIAL-INFARCTION | LIRAGLUTIDE | STATIN THERAPY | BLOOD-GLUCOSE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | RISK | PCSK9 | GENETIC-VARIANTS | ASSOCIATION | EVOLOCUMAB
Journal Article